Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
This glossary (table 1) has been produced to accompany the European Statements of Hospital Pharmacy agreed at a summit in Brussels on 15 May 2014.
In the process of refining the statements in workshops with attendees at the summit on 14 May 2014, it was recognised that there was a clear need for a glossary to accompany the statements. This was to enable readers of the statements who did not partake in the May discussions, to have a common understanding of key terms used in the statements.
Communication is challenging. Not only are the statements in English, which is not the first language for many readers, but words and phrases have different meanings in different countries. In addition, the practice of pharmacy is very different in different member states. The glossary seeks to prevent misunderstandings related to the technical terms used in the statements.
All authors of the glossary were facilitators or observers in the Delphi process, and three (NM, RF, JU) were facilitators in the World Café process (see page 264); David Preece was a note-taker in the World Café process. All were familiar with the technical terms in the European statements for hospital pharmacy which generated discussions about terminology during both processes. Such discussions were the starting point for identifying words and phrases which would form a glossary to accompany the statements. If not identified in discussions, potential sources of the required definitions of terminology were identified through PubMed or internet search engines. When required, snowballing of references was employed. The determinant of the most appropriate sources for the glossary was relevance to the technical discussions which took place in the Delphi and World Café processes.
Contributors NM, in correspondence with DP, developed the approach for the production of the glossary. DP produced a first draft which was added to and refined by NM. RF and JU reviewed and made further suggested amendments which DP incorporated. A final version was then developed by NM. All authors reviewed and approved the final manuscript.
Competing interests NM and JU are employed part time by the National Institute for Health and Care Excellence. RF is President of the European Association of Hospital Pharmacists. DP has no competing interests to declare.
Provenance and peer review Commissioned; internally peer reviewed.